inXso is an innovation agency specialising in breakthrough, disruptive, and emerging technologies for healthcare, covering deep tech and nanotechnology solutions for medical, biomedical, and health technology. Following our motto "We bridge the gap between medical research, the development of medical innovation, and international commercialisation" by providing expertise in co-innovation and development, international business development, and innovation procurement support. Our operations are based on our extensive network of experts in Europe and the Asia-Pacific region up to North America, inter alia. Together with our clients, we tailor a step-by-step process from ideation through research and development to robust business models that meet their innovations and needs. Our approach is user-centric as we work to enhance patient safety in health and medical care technology. From this starting point, we co-create safe-by-design models for our clients, guide them through the diverse international regulatory pathways, and provide specific market info and networks for accelerated market entry. Our projects often involve personalised and precision medicine solutions incorporating such combinations as (bio)medical devices with drug delivery or active therapeutic component, integrated diagnostic systems, and in silico prediction models, including implants and cell and gene therapeutics that are classified in the higher risk classes or borderline cases.